We consider it an honor to serve each and every patient who entrusts their health to us, and we’re constantly awed by the amazing attitudes of our patients. For example, a dear patient recently shared this list about the 7 advantages she’s discovered since having a double-mastectomy:
Read more on Inspiration (And Humor) From A Double-Mastectomy Patient…
Read More Benefits of double mastectomy
It’s always my steadfast mission to know which surgical methods will make patients feel more at ease and reassured that their health is in the best hands possible. This is certainly the case when a biopsy or lumpectomy is required.
One of our beloved patients was recently featured in the Citizen Tribune about her experience with DCIS breast cancer. The information in this blog post was gathered from that article:
Whitney Danehy McGowen was 33 years old when she went for a regular checkup with her obstetrician in the late fall of 2017. She mentioned a slight change in her left breast and her obstetrician, while not overly concerned, suggested it was a good reason to get a baseline mammogram since she had a family history of breast cancer.
Read more on Why One Young Mother Choose A Double Mastectomy After DCIS Diagnosis …
Read More BRCA gene, breast cancer genetic testing, DCIS, Knoxville breast cancer surgeon
The U.S. Food and Drug Administration has recently granted its first approval to an immunotherapy regimen for Triple Negative Breast Cancer, which is significant because Triple Negative Breast Cancer tumors are generally high-grade, aggressive, and typically more likely to spread and recur.
Read more on First Immunotherapy Regimen for Triple-Negative Breast Cancer Approved By FDA…
Read More Immunotherapy for breast cancer, Triple Negative breast cancer treatment
Hands down and without a doubt, mammograms are the best way to detect breast cancer early. Mammograms save lives, and so it’s crucial for every woman to know when she should be having them, and how frequently.
Read more on Clearing Up Confusion Over Recent Mammography Guidelines…
Read More breast cancer treatment Knoxville, Mammogram guidelines
For women diagnosed with hormone-receptor-positive DCIS, a new study has determined that low dose Tamoxifen after surgery reduced the risk of the disease coming back. Low dose tamoxifen also reduced the risk of developing a new invasive breast cancer.
Read more on Low Dose Tamoxifen Reduces Risk Of Recurrence For Some Breast Cancers…
Read More ADH, ALH breast cancers, DCIS, LCIS, reduce breast cancer recurrence
Our Director of Clinical Genetics Service, Imelda G. Margulies, FNP (who is also my beloved wife of 22 years), was featured on WBIR’s Buddy Check 10 series recently. She explained what genetic testing is, how it’s done, and why it’s important.
Read more on Knowledge Is Power When It Comes To Genetic Testing: WBIR Segment…
Read More BRCA gene, Genetic testing and breast cancer
Many patients assume that surgery is the first step towards treatment, and this is true in that doctors do typically recommend surgery to remove a tumor for both early-stage invasive breast cancer and DCIS.
Read more on Can Some Types Of Breast Cancer Be Cured Without Surgery?…
Read More her2-positive breast cancer, Triple Negative Breast Cancer
According to the American Cancer Society, pancreatic cancer is currently the third leading cause of cancer-related deaths in the U.S., and rates are rising faster than any other cancer in the country. Researchers predict it will become the second deadliest cancer in the U.S. by 2030, second only to lung cancer.
Read more on New Research Links BRCA2 Breast Cancer Gene With Pancreatic Cancer Risk…
Read More BRCA gene, pancreatic cancer treatment, PARP-I
We hosted a dinner on PARP Inhibitors recently. PARP Inhibitors are a class of medications that may have benefits in Triple Negative and other Breast Cancers in women with a BRCA mutation. Homologous Recombination Deficiencies are associated with several cancers, including breast cancer, and can be identified in breast cancer tissue itself. Tumors with a homologous recombination deficiency (including BRCA mutations) are described as HRD-positive.
Read more on More Hope For PARP Inhibitors In Treating Breast Cancer…
Read More BRCA gene, HRD, PARP-I, Triple Negative Breast Cancer